90 related articles for article (PubMed ID: 11877052)
1. [Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line].
Ren H; Zhang N; Xu H; Lu D
Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):72-5. PubMed ID: 11877052
[TBL] [Abstract][Full Text] [Related]
2. [Effect of combination of herbimycin A, an inhibitor of tyrosine kinase, and chemotherapeutic agents on apoptosis of K562 cells].
Ren H; Chen S; Lu D
Zhonghua Xue Ye Xue Za Zhi; 1997 May; 18(5):227-30. PubMed ID: 15622750
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of simvastatin-induced K562 cell apoptosis.
Yang YC; Xiao DW; Liu H; Chuan LM; Zeng YL; Zhou DA; Liu W; Xu GQ; Huang WF
Pharmacology; 2009; 84(4):191-5. PubMed ID: 19729986
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
6. Herbimycin A enhances apoptotic effect of chemotherapeutic drugs on K562 cells.
Ren H; Chen S; Lu D
Chin Med J (Engl); 1998 Aug; 111(8):678-81. PubMed ID: 11245017
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells.
Yang YC; Huang WF; Chuan LM; Xiao DW; Zeng YL; Zhou DA; Xu GQ; Liu W; Huang B; Hu Q
Chemotherapy; 2008; 54(6):438-46. PubMed ID: 18824851
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.
Konturek PC; Burnat G; Hahn EG
J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():141-8. PubMed ID: 17901590
[TBL] [Abstract][Full Text] [Related]
10. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase.
Koyuturk M; Ersoz M; Altiok N
Neurosci Lett; 2004 Nov; 370(2-3):212-7. PubMed ID: 15488325
[TBL] [Abstract][Full Text] [Related]
12. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
Jakubowska J; Wasowska-Lukawska M; Czyz M
Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
[TBL] [Abstract][Full Text] [Related]
13. [Effects of prazosin on the proliferation and apoptosis of K562 leukemia cells].
He J; He Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):562-5. PubMed ID: 16320589
[TBL] [Abstract][Full Text] [Related]
14. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
[TBL] [Abstract][Full Text] [Related]
16. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.
Matsuura M; Suzuki T; Suzuki M; Tanaka R; Ito E; Saito T
Oncol Rep; 2011 Jan; 25(1):41-7. PubMed ID: 21109955
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin treatment induces morphology alterations and apoptosis in murine cochlear neuronal cells.
Park DS; So HS; Lee JH; Park HY; Lee YJ; Cho JH; Yoon KH; Park C; Yun K; Park R
Acta Otolaryngol; 2009 Feb; 129(2):166-74. PubMed ID: 18607908
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor.
Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K
Biochem Biophys Res Commun; 2008 Jul; 372(2):356-61. PubMed ID: 18489904
[TBL] [Abstract][Full Text] [Related]
20. The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol.
Flach J; Antoni I; Villemin P; Bentzen CL; Niesor EJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):240-6. PubMed ID: 10733934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
